Mark Devries
Stock Analyst at Barclays
Total Price Targets
8
Stocks Covered
7
Sectors
Financial Services, Industrials, Real Estate
Most Recent
Jan 29, 2024
Stocks Covered by Mark Devries
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| AXP | American Express Company | $220.00 | $320.01 | -31.3% | 2 | Jan 29, 2024 |
| SOFI | SoFi Technologies, Inc. | $11.00 | $16.56 | -33.6% | 1 | Jan 10, 2024 |
| AGNC | AGNC Investment Corp. | $8.00 | $10.96 | -27.0% | 1 | Dec 11, 2023 |
| AER | AerCap Holdings N.V. | $78.00 | $141.07 | -44.7% | 1 | Jul 31, 2023 |
| OMF | OneMain Holdings, Inc. | $46.00 | $57.08 | -19.4% | 1 | Mar 9, 2023 |
| SYF | Synchrony Financial | $64.00 | $75.89 | -15.7% | 1 | Jan 10, 2022 |
| ARCC | Ares Capital Corporation | $20.00 | $19.27 | +3.8% | 1 | Jul 29, 2021 |
Recent Activity
- Jan 29, 2024— Set$220.00price target onAXP(American Express Company)
- Jan 10, 2024— Set$11.00price target onSOFI(SoFi Technologies, Inc.)
- Dec 11, 2023— Set$8.00price target onAGNC(AGNC Investment Corp.)
- Jul 31, 2023— Set$78.00price target onAER(AerCap Holdings N.V.)
- Mar 9, 2023— Set$46.00price target onOMF(OneMain Holdings, Inc.)
- Jan 26, 2022— Set$190.00price target onAXP(American Express Company)
- Jan 10, 2022— Set$64.00price target onSYF(Synchrony Financial)
- Jul 29, 2021— Set$20.00price target onARCC(Ares Capital Corporation)
Frequently Asked Questions
Who is Mark Devries?
Mark Devries is a stock analyst at Barclays covering 7 stocks primarily in Financial Services, Industrials, Real Estate. They have issued 8 price targets since Jul 29, 2021.
What stocks does Mark Devries cover?
Mark Devries currently covers 7 stocks, including AXP, SOFI, AGNC, AER, OMF.
What is Mark Devries's latest price target?
Mark Devries's most recent price target was $220.00 on AXP (American Express Company), set on Jan 29, 2024.
What is Mark Devries's highest price target?
Mark Devries's highest issued price target is $220.00 on AXP, set on Jan 29, 2024.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.